GSS Genetic Signatures Limited
Healthcare · Diagnostics & Research
· website
$0.08
52wk 0.05 – 0.43
Overall
50.6
Value
99.7
Growth
1.3
Health
100.0
Quality
0.0
Momentum
35.8
Dividend
—
Price
About Genetic Signatures Limited
Genetic Signatures Limited operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas. The company offers enteric bacteria, Enteroaggregative E.coli aggR and aaiC, enteric viral, enteric protozoan, enteric protozoan extended, enteric microsporidia, respiratory pathogen, SARS-CoV-2, extended respiratory, atypical respiratory, Measles, Mumps, and Rubella detection kits under the EasyScreen name. Genetic Signatures Limited was incorporated in 2001 and is headquartered in Newtown, Australia.
Price analytics
Returns
| 1 day | 1.3% |
| 1 week | 1.3% |
| 1 month | -9.2% |
| 3 months | 25.4% |
| 6 months | -1.2% |
| 1 year | -69.0% |
| 3 years | -83.8% |
Risk
| Volatility (1y ann.) | 129.5% |
| Beta vs ASX 200 | 0.16 |
| Sharpe (1y) | -0.37 |
| VaR 95% (1-day) | -9.6% |
| Max drawdown (1y) | -86.1% |
| Off 1-year high | -79.2% |
Technicals
| RSI(14) | 47 |
| vs 50DMA | 10.5% |
| vs 200DMA | -23.7% |
| Trend | Death cross |
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value
99.7
Trailing P/E
—
Forward P/E
100
PEG ratio
—
EV / EBITDA
100
Price / Book
100
Price / Sales
99
Growth
1.3
Revenue growth (1y)
3
Revenue CAGR (3y)
0
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health
100.0
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
—
Current ratio
100
Debt / Equity
100
Quality (Profitability & Cash Flow)
0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income
—
No meaningful dividend — pillar excluded from the overall score.
Momentum
35.8
6-month return vs ASX 200
42
Price vs 200-day average
0
Price vs 50-day average
100
Position in 52-week range
7
Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).
Score history
Key metrics
Market cap
$17.94M
P/E (trailing)
—
P/E (forward)
-1.76
EPS (trailing)
-0.06
Dividend yield
—
Payout ratio
0.0%
Beta
0.58
EV / EBITDA
0.34
Price / Book
0.50
ROE
-32.6%
Operating margin
-56.4%
Net margin
-72.5%
Total cash
$22.09M
Total debt
$310,000
Current ratio
13.10
Debt / Equity
0.01
Free cash flow
$-5.10M
Avg volume
337,963
Latest annual results
(FY ending 30 Jun 2026)
- Revenue$14.45M
- Gross profit$4.99M
- Operating income-$17.74M
- Net income-$14.01M
- Diluted EPS—
- Free cash flow-$8.82M
- Net debt-$8.76M